CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.

Pubmed id
26261308
Authors

Hammitzsch A, Tallant C, Fedorov O, O'Mahony A, Brennan PE, Hay DA, Martinez FO, Al-Mossawi MH, de Wit J, Vecellio M, Wells C, Wordsworth P, Müller S, Knapp S, Bowness P

DOI
10.1073/pnas.1501956112
Journal
Proc. Natl. Acad. Sci. U.S.A.
Publication Date
2015-8-10
Year
2015
N Publication Date
PI authors
Validated
Y